Abstract
Boston—Researchers reported at a meeting in Boston two promising strategies for preventing the body from rejecting tissue transplanted from another species. One involves treating the transplanted tissue with anti-oxidant drugs to prevent host blood that rushes into the transplant from damaging a key enzyme. The other, more controversial, strategy involves genetically engineering the donor animal to express human immune regulators in its tissues. In theory, tissue from such animals should itself suppress an acute rejection response when it is transplanted into humans.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
